NO20011268L - Forbindelse til behandling av depresjon - Google Patents

Forbindelse til behandling av depresjon

Info

Publication number
NO20011268L
NO20011268L NO20011268A NO20011268A NO20011268L NO 20011268 L NO20011268 L NO 20011268L NO 20011268 A NO20011268 A NO 20011268A NO 20011268 A NO20011268 A NO 20011268A NO 20011268 L NO20011268 L NO 20011268L
Authority
NO
Norway
Prior art keywords
depression
treatment
connection
isobenzo
indol
Prior art date
Application number
NO20011268A
Other languages
English (en)
Other versions
NO20011268D0 (no
Inventor
Connie Sanchez
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20011268D0 publication Critical patent/NO20011268D0/no
Publication of NO20011268L publication Critical patent/NO20011268L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)

Abstract

Forbindelsen l'-[4-[l-(4-fluorfenyl)-lH-indol-3-yl]-1- butyl]-spiro[isobenzo-furan-l(3H),4'-piperidin]er aktiv i modeller forutsigbare for antidepressive effekter og er nyttig for fremstillingen av et medikament for behandling av depresjoner eller sykdommer assosiert med depressive symptomer.
NO20011268A 1998-09-15 2001-03-13 Forbindelse til behandling av depresjon NO20011268L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199801163 1998-09-15
PCT/DK1999/000482 WO2000015225A1 (en) 1998-09-15 1999-09-14 Treatment of depression

Publications (2)

Publication Number Publication Date
NO20011268D0 NO20011268D0 (no) 2001-03-13
NO20011268L true NO20011268L (no) 2001-05-15

Family

ID=8101704

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011268A NO20011268L (no) 1998-09-15 2001-03-13 Forbindelse til behandling av depresjon

Country Status (25)

Country Link
US (1) US6358966B2 (no)
EP (1) EP1121122A1 (no)
JP (1) JP2002524515A (no)
KR (1) KR20010075120A (no)
CN (1) CN1317969A (no)
AR (1) AR021805A1 (no)
AU (1) AU5617499A (no)
BG (1) BG105378A (no)
BR (1) BR9913964A (no)
CA (1) CA2343761A1 (no)
CZ (1) CZ2001946A3 (no)
EA (1) EA200100355A1 (no)
HK (1) HK1040922A1 (no)
HR (1) HRP20010191A2 (no)
HU (1) HUP0103568A3 (no)
ID (1) ID29414A (no)
IL (1) IL141880A0 (no)
IS (1) IS5873A (no)
NO (1) NO20011268L (no)
PL (1) PL346528A1 (no)
SK (1) SK3502001A3 (no)
TR (1) TR200100767T2 (no)
WO (1) WO2000015225A1 (no)
YU (1) YU18701A (no)
ZA (1) ZA200101910B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR030453A1 (es) * 2000-08-15 2003-08-20 Lundbeck & Co As H Composicion farmaceutica con contenido de 1' [4-[1-(4-fluorofenil)-1h-indol-3-il]-1-butil] espiro [isobenzofuran-1 (3h), 4'-piperidina]

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
EP1069899A1 (en) * 1998-04-07 2001-01-24 H. Lundbeck A/S Treatment of panic attacks

Also Published As

Publication number Publication date
NO20011268D0 (no) 2001-03-13
HUP0103568A2 (hu) 2002-01-28
YU18701A (sh) 2003-07-07
EA200100355A1 (ru) 2001-08-27
TR200100767T2 (tr) 2001-07-23
BR9913964A (pt) 2001-07-03
CA2343761A1 (en) 2000-03-23
US20010020027A1 (en) 2001-09-06
CN1317969A (zh) 2001-10-17
JP2002524515A (ja) 2002-08-06
KR20010075120A (ko) 2001-08-09
AU5617499A (en) 2000-04-03
IS5873A (is) 2001-02-28
US6358966B2 (en) 2002-03-19
IL141880A0 (en) 2002-03-10
PL346528A1 (en) 2002-02-11
ID29414A (id) 2001-08-30
SK3502001A3 (en) 2001-12-03
AR021805A1 (es) 2002-08-07
HK1040922A1 (zh) 2002-06-28
ZA200101910B (en) 2001-09-11
EP1121122A1 (en) 2001-08-08
HRP20010191A2 (en) 2002-04-30
HUP0103568A3 (en) 2003-05-28
BG105378A (bg) 2001-12-29
CZ2001946A3 (cs) 2001-09-12
WO2000015225A1 (en) 2000-03-23

Similar Documents

Publication Publication Date Title
Coleman et al. Auditory brainstem responses after ovariectomy and estrogen replacement in rat
DK1082106T3 (da) Brusemiddeltablet til sublingual, bukkal og gingival administration af fentanyl
ATE468845T2 (de) Bukkale transmukosale arzneidarreichung unter verwendung einer festen lösung
ES2123064T3 (es) Uso de melatonina en pequeñas dosis orales como somnifero.
ATE232089T1 (de) Implantierbare wiederauffüllbare vorrichtung mit gesteuerter freisetzung zur verabreichung von arzneistoffen unmittelbar an einen inneren teil des körpers
RU94040387A (ru) Композиция, способствующая прекращению курения, никотиносодержащий распыляемый раствор, способ снижения потребности в курении табака, способ замены курения табака
YU49026B (sh) UPOTREBA 17 Гџ -(N-TERC-BUTILKARBAMOIL)-4-AZA-5-ALFA-ANDROST-1-3-ON ZA PROIZVODNJU LEKA ZA TRETIRANJE ANDROGENE ALOPECIJE
GB8908085D0 (en) New therapeutic use
PT87542A (pt) Process for the preparation of a medicament based on indolone derivatives for the treatment of the parkinson disease
SE9703191D0 (sv) Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases
TR200001267T2 (tr) 1'-[4-Florofenil)-1H-Indol-3-İl] -1-Bütil1-Spiro[izobenzofüran- 1(3H), 4'-Piperidin] hidrohalojenitler
AR032440A1 (es) Metodo para reducir o eliminar el tabaquismo
NO20011268L (no) Forbindelse til behandling av depresjon
FI974578A (fi) Menetelmä levosimendaanin antamiseksi
NO982863L (no) Nye forbindelser med analgetisk effekt
IT1254280B (it) Composizioni farmaceutiche comprendenti monosialoganglioside gm1 o un suo derivato atte al trattamento della malattia di parkinson
NO20005062L (no) Behandling av panikkanfall
ES2184561A1 (es) Forma farmaceutica solida de administracion oral dispersable en agua para el tratamiento de la tuberculosis conteniendo refampicina, isoniazida, pirazinamida y piridoxina hidrocloruro, procedimiento para su obtencion y forma de presentacion de dicha forma farmaceutica.
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
HUP9701284A2 (hu) 2,3-Benzodiazepin-származékok felhasználása az endogén opioid rendszerrel összefüggő betegségek és állapotok kezelésére, és megelőzésére alkalmas gyógyászati készítmények előállítására
SE9904424D0 (sv) Use of interleukin-6 in combination with leptin in treatment of obesity
IT1276040B1 (it) Uso della benzidamina nel trattamento di stati patologici causati dal tnf
RU97116821A (ru) Способ лечения респираторных заболеваний
DK0615446T3 (da) Retard-lægemiddel indeholdende et dihydropyridinderivat i nanosolform og fremstilling heraf
RU95106139A (ru) Способ лечения туберкулеза легких

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application